Search

Search Results
Results 441 - 450 of 1413 for Active treatment
  • DBL Sodium Phosphate and Potassium Phosphate
    Drug - 30 Jan 2023
    Consumer Medicine Information (CMI) about DBL Sodium Phosphate and Potassium Phosphate intended for persons living in Australia.
  • DBL Potassium Acetate Concentrated Injection
    Drug - 30 Jan 2023
    Consumer Medicine Information (CMI) about DBL Potassium Acetate Concentrated Injection intended for persons living in Australia.
  • DBL Potassium Dihydrogen Phosphate Concentrated
    Drug - 30 Jan 2023
    Consumer Medicine Information (CMI) about DBL Potassium Dihydrogen Phosphate Concentrated intended for persons living in Australia.
  • Telzir Tablets
    Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Telzir Tablets intended for persons living in Australia.
  • Actemra PFP AI
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Actemra PFP AI intended for persons living in Australia.
  • Alunbrig
    Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Alunbrig intended for persons living in Australia.
  • Retrovir
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Retrovir intended for persons living in Australia.
  • Zidoval
    Drug - 28 Nov 2022
    Consumer Medicine Information (CMI) about Zidoval intended for persons living in Australia.
  • Actemra PFS
    Drug - 24 Nov 2022
    Consumer Medicine Information (CMI) about Actemra PFS intended for persons living in Australia.
  • Jinarc
    Drug - 4 Nov 2022
    Consumer Medicine Information (CMI) about Jinarc intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback